25 of the Best Pediatricians Near Me in Bolling Afb, DC

Leslie Castelo-Soccio, MD, PhD, is a dermatologist at Children's National Hospital and professor of Pediatrics and Dermatology at the George Washington University School of Medicine and Health Sciences. She is an expert in hair disorders most notably alopecia areata as well as other autoimmune skin diseases. Her interests and expertise include hair, genetic skin disorders, neonatal dermatology, inflammatory skin diseases such as eczema/atopic dermatitis and psoriasis, pigmented lesions (moles), acne and vascular disorders. She is an expert in laser and surgical treatment for pediatric patients and provides services in the clinic and operating room. Dr. Castelo-Soccio has built a research career in alopecia and inflammatory skin disease and runs clinical trials on these diseases at Children's National. Dr. Castelo-Soccio has published extensively including peer-reviewed articles and book chapters on pediatric and medical dermatology. She is a national and international speaker on hair disorders and autoimmune skin disease. She is a member of the board of directors of the American Hair Research Association and has worked closely as a volunteer for the National Alopecia Areata Foundation and the Pediatric Dermatology Research Alliance. Dr. Castelo-Soccio received her bachelor's degree with honors in biological sciences from Harvard University and her MD and PhD from Cornell University - Weill Medical College. She completed residency training in dermatology at the University of Pennsylvania and her fellowship training in pediatric dermatology at the Children's Hospital of Philadelphia. She is board certified in dermatology and pediatric dermatology. From 2011-2021 she was an attending physician at Children's Hospital of Philadelphia. From 2021-2025 she was an attending physician and researcher at the National Institutes of Health, where she still serves as a special volunteer. Dr. Castelo is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Alopecia Areata, Lamellar Ichthyosis, and Nonbullous Congenital Ichthyosiform Erythroderma. Dr. Castelo is board certified in American Board Of Dermatology, 2012 and Dermatology: American Board Of Dermatology, 2009.

Nicholas Ah Mew, MD, is director of the Inherited Metabolic Disorders Program at Children’s National Hospital and is associate professor of Pediatrics at The George Washington University. He is a clinical geneticist and clinical biochemical geneticist whose primary research interests include urea cycle disorders, organic acidemias, and other disorders of ammonia metabolism. He is the principal investigator or co-PI of several projects funded through the National Institutes of Health and Patient-Centered Outcomes Research Institute. Dr. Ah Mew is the Children’s National site-PI and an active member of the NIH-funded Urea Cycle Disorders Consortium (UCDC). He has authored multiple publications and book chapters on hyperammonemia and urea cycle disorders and has lectured internationally on these topics. Dr. Mew is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Maple Syrup Urine Disease, Argininosuccinic Aciduria, and Propionic Acidemia. Dr. Mew is board certified in American Board Of Medical Genetics And Genomics, 2020 and Clinical Biochemical Genetics: American Board Of Medical Genetics And Genomics, 2011.

David Jacobsohn, MD, ScM, MBA, is the division chief of the Blood and Marrow Transplantation Program at Children’s National Hospital and full professor of Pediatrics at the George Washington University. He leads a program of upwards of 70 pediatric transplants per year. The program performs transplants in patients with malignant and non-malignant conditions, and has expertise with all stem cell sources including haplo-identical transplants. His expertise is in graft-versus-host disease (GvHD) clinical trials: reducing incidence of GvHD as well as novel therapies for GvHD. He has more than 10 years of experience in clinical research in pediatric GvHD. His work has included the study of novel drugs for chronic GvHD, classification criteria for chronic GvHD, and risk factor stratification in pediatric chronic GvHD. He is active in the BMT community at a national level. Examples of some current and prior roles include head of the GVHD committee for the Pediatric Blood and Marrow Transplant Consortium, member-at-large of the that Consortium, member of the Children’s Oncology Group Stem Cell Transplant Committee, member of the Clinical Trials Network State of the Science Pediatric Advisory Group. Dr. Jacobsohn has been instrumental in growing the capabilities of the Blood and Marrow Transplant Program. For example, for the last five years the program is one of the few pediatric programs performing alpha/beta T cell depletion for haploidentical transplants. This novel method for GVHD prevention has significantly improved the outcome of haploidentical BMT at Children’s National. Additionally, he has been involved with the deployment of gene therapy for hemoglobinopathies. He successfully led Children’s National to become the first program in the country to collect stem cells for a commercial sickle cell gene therapy treatment. Dr. Jacobsohn is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Hemoglobinopathy, Anemia, Sickle Cell Disease, and Bone Marrow Transplant. Dr. Jacobsohn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1999.

Robert Nickel is a Hematologist and a Pediatrics provider practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Nickel is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, and Bone Marrow Transplant. Dr. Nickel is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2015, Blood Banking/Transfusion Medicine: American Board Of Pathology, 2015, and Pediatrics: American Board Of Pediatrics, 2011.

Seth Berger, MD, PhD, returned to Children’s National Hospital as faculty in 2018. He completed the medical scientist training program at Mount Sinai School of Medicine in New York where he was awarded his MD and PhD degrees. His research at that time focused on computational analysis of signaling networks applied to prediction of adverse drug events and cardiac arrhythmia syndromes. He subsequently completed the combined pediatrics and medical genetics residency program through Children's National and the National Human Genome Research Institute at the National Institutes of Health (NIH). He spent an additional year completing the medical biochemical genetics fellowship program at NIH before returning to Children's National where he was jointly hired by the Rare Disease Institute and the Center for Genetic Medicine Research. He is interested in developing novel bioinformatics approaches applied to variant discovery for rare diseases. Dr. Berger is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Alpha Thalassemia. Dr. Berger is board certified in Medical Biochemical Genetics: American Board Of Medical Genetics And Genomics, 2019, Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2017, and Pediatrics: American Board Of Pediatrics, 2016.

Andrea Estrada is a Pediatric Endocrinologist practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 17 years. Dr. Estrada is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Mccune-Albright Syndrome, Osteitis Fibrosa, Albright's Hereditary Osteodystrophy, and Pseudohypoparathyroidism. Dr. Estrada is board certified in Pediatric Endocrinology: American Board Of Pediatrics, 2015 and Pediatrics: American Board Of Pediatrics, 2012.

Joshua Kanter, MD, is medical director of the Cardiac Catheterization Laboratory at Children’s National Hospital and associate professor of pediatrics at the George Washington University Medical Center. He received his medical degree and pediatrics training from the State University of New York, Health Science Center at Syracuse and completed fellowship training in pediatric cardiology and interventional pediatric cardiology at the New York Presbyterian Hospital, Columbia University Medical Center. Dr. Kanter specializes in diagnostic and interventional pediatric cardiac catheterization for the treatment of congenital heart disease. He has extensive experience with transcatheter pulmonary valve implantation and is an expert in the device closure of atrial septal defects, ventricular septal defects and patent ductus arteriosus. Dr. Kanter is the site principal investigator on the RO1 grant titled “Cardiac MRI Increases Accuracy and Decreases Risk of Evaluation of Children with Cardiomyopathy and Cardiac Transplantation” funded by the National Heart Lung and Blood Institute of the National Institutes of Health. He has also been an investigator in several national multi-center research studies to examine new interventional devices and to track clinical outcomes. He has served on several national committees including the American College of Cardiology, National Cardiovascular Data Registry, IMPACT™ Registry Implementation Group and the American College of Cardiology Annual Scientific Session Program Committee. Dr. Kanter is board certified in pediatric cardiology and is a fellow of the American College of Cardiology. He has published extensively on a range of topics within the field of interventional pediatric cardiology. Publications Google Scholar|ORCID. Dr. Kanter is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Dextrocardia, Dextrocardia with Situs Inversus, Pulmonary Atresia, Heart Transplant, and Angioplasty. Dr. Kanter is board certified in Pediatric Cardiology: American Board Of Pediatrics, 2004 and Pediatrics: American Board Of Pediatrics, 2002.

Jonathan Murnick, MD, PhD, is an attending neuroradiologist in the department of Diagnostic Imaging and Radiology at Children’s National Hospital. Dr. Murnick has a special interest in brain development in the term and preterm neonate, as well as in diagnosis and prevention of pediatric stroke. Dr. Murnick received his medical degree from Harvard University and his doctoral degree from the Massachusetts Institute of Technology. He completed residency in diagnostic radiology and fellowship in neuroradiology at Massachusetts General Hospital. Following his fellowship, he joined the faculty at Children’s National and The George Washington University School of Medicine & Health Sciences. Dr. Murnick is board-certified in diagnostic radiology and neuroradiology and specializes in imaging of children with neurologic disorders. Dr. Murnick is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Premature Infant, Cortical Dysplasia, Schizencephaly, and Intraventricular Hemorrhage of the Newborn. Dr. Murnick is board certified in Neuroradiology: American Board Of Radiology, 2012 and Diagnostic Radiology: American Board Of Radiology, 2010.

Sarah Kollar is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 10 years. Dr. Kollar is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Tetralogy of Fallot, Congenital Cardiovascular Shunt, Congenital Heart Disease (CHD), and Becker Muscular Dystrophy. Dr. Kollar is board certified in American Board Of Pediatrics, 2024 and Pediatrics: American Board Of Pediatrics, 2019.

Elaise Hill is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. She has been practicing medicine for over 13 years. Dr. Hill is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), and Asthma in Children. Dr. Hill is board certified in Pediatric Emergency Medicine: American Board Of Pediatrics, 2021 and Pediatrics: American Board Of Pediatrics, 2016.

Steven L. Shein, MD, FCCM, earned his Bachelor’s degree as an Echols Scholar at the University of Virginia in 2001 and his Medical degree from Case Western Reserve University School of Medicine in 2005, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his pediatrics residency at Rainbow Babies and Children’s Hospital and his Pediatric Critical Care Medicine Fellowship at the Children’s Hospital of Pittsburgh. Prior to joining Children’s National, Dr. Shein served as chief of the Division of Pediatric Critical Care Medicine at Rainbow Babies and Children's Hospital. He oversaw the Pediatric ICU and Pediatric Sedation Unit service lines, co-directed the PICU Fellowship Program and the PICU Research Program, held the Linsalata Family Distinguished Chair in Pediatric Critical Care and Emergency Medicine and was a Professor of Pediatrics at Case Western. He also completed leadership training through the Harvard T.H. Chan School of Public Health and the Association of Medical School Pediatric Department Chairs, among others. An accomplished researcher, he has authored more than 120 peer-reviewed manuscripts and numerous book chapters; co-founded BACON (Bronchiolitis: Advancing Care and Outcomes Network), the bronchiolitis research subgroup of PALISI—the largest PICU research collaborative in the world; and has been an invited expert for several national and international initiatives related to acute respiratory failure, including the second Pediatric Acute Lung Injury Consensus Conference and the American Academy of Pediatrics’ HIFLO project to reduce unnecessary high-flow nasal cannula use. His contributions have been recognized with election as a Fellow of the American College of Critical Care Medicine, designation as a University Hospitals Distinguished Physician and multiple Presidential Citations from the Society of Critical Care Medicine. Dr. Shein is highly rated in 1 condition, according to our data. His clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Cerebral Hypoxia, Venous Thromboembolism (VTE), and Subglottic Stenosis. Dr. Shein is board certified in Pediatric Critical Care Medicine: American Board Of Pediatrics, 2008 and Pediatrics: American Board Of Pediatrics, 2008.

Andrea Gropman is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Gropman is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Klinefelter Syndrome, Urea Cycle Disorders (UCD), MELAS Syndrome, Ornithine Transcarbamylase Deficiency, and Hormone Replacement Therapy (HRT).

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.

Hans Pohl is a Pediatrics specialist and a Urologist practicing medicine in Washington, Washington, D.c.. Dr. Pohl is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Ureterocele, Urinary Tract Infection (UTI), Orchiectomy, and Ureteral Reconstruction.

Claire Lawlor is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Lawlor is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Tracheobronchomalacia, Tongue Tie, Laryngomalacia, Endoscopy, and Myringotomy. Dr. Lawlor is board certified in Otolaryngology-Head And Neck Surgery and Complex Pediatric Otolaryngology.

Mendel Tuchman is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Tuchman is highly rated in 4 conditions, according to our data. His clinical expertise encompasses N-Acetylglutamate Synthase Deficiency, Urea Cycle Disorders (UCD), Carbamoyl Phosphate Synthetase 1 Deficiency, and Argininosuccinic Aciduria.

Lisa Guay is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Guay is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Polycystic Kidney Disease, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, and Focal Segmental Glomerulosclerosis.

Jose Millan is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Millan is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Hypophosphatasia (HPP), Malnutrition, Childhood Hypophosphatasia (HPP), and Hypercementosis.

Eric Ottesen is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Ottesen is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lymphatic Filariasis.

Amanda Castel is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Castel is highly rated in 1 condition, according to our data. Her clinical expertise encompasses HIV/AIDS and Monkeypox.

Briony K. Varda, MD, MPH, is an urologist in the Division of Urology and the Division of Colorectal and Pelvic Reconstruction at Children’s National Hospital. She is also the director of research for each division and an assistant professor in Urology and Pediatrics at the George Washington School of Medicine and Health Sciences. She is fellowship-trained in pediatric urology and board-certified in adult and pediatric urology. Dr. Varda received the 2025 SMHS Early Career Clinical Scientist Research Achievement Award from George Washington University, which included a small grant intended for dissemination of knowledge. In 2025 and 2023, Dr. Varda was recognized by the Washingtonian as a top doctor in urology. Dr. Varda is an expert in reconstructive urology for congenital anomalies of the urinary tract, pelvic floor and neurogenic bladder. Her subspecialty interests include the care of patients born with cloacal anomalies, cloacal exstrophy, urological anomalies associated with anorectal malformations, vesicoureteral reflux, hydronephrosis, hydroureter, urinary tract infection and neurogenic bladder related to abnormalities of the spinal cord (e.g. myelomeningocele and tethered cord syndrome). She accepts local, national and international referrals for these complex conditions, as well as second-opinion referrals. Dr. Varda completed her residency in the Harvard-Longwood Program in urology and her fellowship at Boston Children’s Hospital prior to joining Children’s National. She has a Master of Public Health from the Harvard T.H. Chan School of Public Health. She leads a research lab focused on collaborative multidisciplinary research in health services and clinical outcomes. The lab is also a setting to train current trainees to be future surgeon-scientists. Her personal research centers around long-term clinical outcomes among patients born with cloacal malformations and curbing low-value healthcare utilization by children with spina bifida. She has authored numerous journal articles and chapters in these areas. As a physician, Dr. Varda is passionate about providing excellent care to all patients. As a mother herself, she believes connecting with families is integral. Her philosophy surrounding complex surgical care is that the surgeon and the family need to be a team every step of the way, relying on mutual trust and shared decision-making to deal with the clinical challenges unique to each patient. Dr. Varda is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Hydronephrosis, Urinary Tract Infection (UTI), Nephrectomy, and Reconstructive Urology Surgery. Dr. Varda is board certified in American Board Of Urology, 2023 and Urology: American Board Of Urology, 2022.

Kuntal Sen, MD, is the co-director of Neurogenetics Clinic in the Division of Neurogenetics and Neurodevelopmental Pediatrics at Children's National Hospital. He is a graduate of Grant Government Medical College, Mumbai. He completed a combined pediatrics-medical genetics and genomics residency at the Detroit Medical Center/Wayne State University of Medicine. He then completed a child neurology fellowship at Children’s National. He also worked at the National Institutes of Health as a volunteer for the Undiagnosed Diseases Program. He is one of the few physicians in the country with dual training in neurology and clinical genetics which affords him a unique expertise to diagnose and manage patients with complex monogenic neurological disorders. Dr. Sen’s clinical expertise is centered on providing long-term, holistic, and family-centered care for patients with mitochondrial diseases and other ultra-rare neuro-metabolic disorders. Dr. Sen's research focus is on multi-modal neuroimaging and neuromonitoring in inborn errors of metabolism. Dr. Sen has published several peer-reviewed articles and presented at many international conferences on newborn screening disorders, rare neurometabolic epilepsies and ethics in genetic testing. Dr. Sen spearheaded a national survey aimed at identifying innovative approaches to educate child neurologists about genomic testing. This initiative culminated in the development and release of a national curriculum through the Child Neurology Society, under his leadership. He was elected chair of the Neurogenetics Section of the American Academy of Neurology, reflecting his national recognition in the field. He is a fellow of the American College of Medical Genetics (ACMG) and a member of the ACMG Advocacy and Government Affairs Committee. He also serves as the media editor for the Pediatric Neurology Journal. During his medical training, he has won awards and grants from professional societies including the prestigious ACMG Foundation/Perkin Elmer Award and Children’s National Founders Auxiliary Board Grant. Publications Google Scholar. Dr. Sen is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Urea Cycle Disorders (UCD), Hydranencephaly, Lissencephaly 2, and Cortical Dysplasia. Dr. Sen is board certified in American Board Of Psychiatry And Neurology, 2022 and Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2019.

Lindsay Kilburn, MD, comes to Children's National Hospital from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Dr. Kilburn is an associate professor, pediatrics at George Washington University School of Medicine. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family. Dr. Kilburn is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Optic Glioma. Dr. Kilburn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2004.

Veronica Gomez-Lobo, MD, is an obstetrician gynecologist who specializes in pediatric and adolescent gynecology. After receiving her Doctor of Medicine degree from Georgetown University, she completed her internship at Thomas Jefferson University Hospital and residency at Tufts University. Prior to her recruitment to NICHD, Dr. Gomez-Lobo was the director and fellowship director of Pediatric and Adolescent Gynecology and professor of Obstetrics and Gynecology at Georgetown University and provided care at MedStar Washington Hospital Center (MWHC), Children’s National Hospital and MedStar Georgetown University Hospital. She also served as site principal investigator for the National Physician’s Consortium as well as the Disorders of Sex Development-Translational Research Network at Children’s National. She has published and lectured extensively regarding the issues in the field of pediatric gynecology as well as obstetrics and gynecology issues in transplant recipients. She currently serves as senior clinician and director of the Pediatric and Adolescent Gynecology (PAG) Program within NICHD. Her areas of focus include fertility preservation, differences in sex development and congenital anomalies of the reproductive tract. Dr. Gomez is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Intersex, Turner Syndrome, Vaginal Agenesis, Oophorectomy, and Intrauterine Device Insertion. Dr. Gomez is board certified in Obstetrics And Gynecology: American Board Of Obstetrics And Gynecology, 1995.

"Eugene (Gene) Hwang, MD, is chief of the Division of Oncology at Children’s National Hospital in Washington, D.C. He is also part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials focused on gene therapy and new, targeted agents. He is the site Principal Investigator of the Pediatric Brain Tumor Consortium, where he is the co-chair of the Immunotherapy Working Group. He serves on grant review committees and on the scientific advisory boards of several large foundations. For each patient, Dr. Hwang carefully considers the best possible options for treatment, trying new, cutting edge treatments coupled with the best available known therapies. Dr. Hwang is not only dedicated to finding a cure for cancer, but also to making the current treatments as safe as possible for children: ""We often focus on curing the children - that's the number one goal - but we also need to pay attention to the toxicity of these treatments, and what quality of life the children will have after treatment."" Dr. Hwang is involved in several international efforts to study how to best mitigate treatment side effects. In the meantime, Dr. Hwang makes sure he is doing everything he can to combat pain, dizziness, fatigue and other common side effects of cancer treatments by leveraging the multidisciplinary team approach of Children's National. He sees this as something the organization does exceptionally well, and thinks that having so many people focus on a single patient in a single visit is crucial to well-being during cancer treatment.". Dr. Hwang is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Pineocytoma, Glioma, Medulloblastoma, and Pineoblastoma. Dr. Hwang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2005.